UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Lessened by Mader & Shannon Wealth Management Inc.

Mader & Shannon Wealth Management Inc. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% during the 4th quarter, HoldingsChannel reports. The fund owned 13,070 shares of the healthcare conglomerate’s stock after selling 417 shares during the period. UnitedHealth Group comprises 4.1% of Mader & Shannon Wealth Management Inc.’s portfolio, making the stock its 8th biggest holding. Mader & Shannon Wealth Management Inc.’s holdings in UnitedHealth Group were worth $6,612,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the stock. Advyzon Investment Management LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $994,000. WealthBridge Capital Management LLC increased its holdings in shares of UnitedHealth Group by 1.2% in the fourth quarter. WealthBridge Capital Management LLC now owns 1,965 shares of the healthcare conglomerate’s stock worth $994,000 after purchasing an additional 23 shares during the period. Sunpointe LLC increased its holdings in shares of UnitedHealth Group by 6.5% in the fourth quarter. Sunpointe LLC now owns 2,930 shares of the healthcare conglomerate’s stock worth $1,482,000 after purchasing an additional 179 shares during the period. Parthenon LLC increased its holdings in shares of UnitedHealth Group by 12.3% in the fourth quarter. Parthenon LLC now owns 546 shares of the healthcare conglomerate’s stock worth $276,000 after purchasing an additional 60 shares during the period. Finally, Financial Perspectives Inc increased its holdings in shares of UnitedHealth Group by 7.2% in the fourth quarter. Financial Perspectives Inc now owns 4,459 shares of the healthcare conglomerate’s stock worth $2,256,000 after purchasing an additional 300 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Stephens upped their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Finally, Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Up 2.0 %

UNH opened at $510.75 on Thursday. The firm has a market capitalization of $470.03 billion, a price-to-earnings ratio of 32.95, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business has a 50 day simple moving average of $520.62 and a two-hundred day simple moving average of $561.67. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the business posted $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.